Tasc Pharma raises $50mn via FCCBs

 According to a release issued by Tasc Pharmaceuticals to the BSE today, the bonds have a maturity of 5 years, and are convertible at Rs 336.92 per share - a premium of 26% over the closing price of Rs 267.40 on the BSE on October 13, 2005.

 The bonds will be listed on the Singapore Exchange Securities Trading, the release added.